BridgeMD
New treatment option for Lymphedema
Official title Impact of Virtual Reality (VR) Based Exercises on Lower Limb Lymphedema Outcomes (LELO)
ClinicalTrials.gov ID: NCT07472543
What this study is testing
- What it's testing
- This randomized controlled study aims to investigate the effects of virtual reality (VR)-assisted gait training, in addition to Complex Decongestive Therapy (CDT), on gait parameters, physical function, quality of life, and edema levels in patients with lower extremity lymphedema. Lymphedema is a progressive condition characterized by the accumulation of protein-rich fluid due to lymphatic drainage insufficiency, leading to chronic inflammation and fibrosis.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Age between 18 and 65 years
- Diagnosis of unilateral lower extremity lymphedema following gynecological and/or oncological surgery
- Stage 2 or 3 lymphedema
You likely can't join if
- Decompensated heart, lung, or kidney failure
- Uncontrolled hypertension
- Presence of systemic infection
- Local infections in the lower extremity such as erysipelas or cellulitis
- Venous insufficiency (e.g., deep vein thrombosis)
- Any neuromuscular or orthopedic disease affecting lower extremity walking
See the full eligibility criteria
- Age between 18 and 65 years
- Diagnosis of unilateral lower extremity lymphedema following gynecological and/or oncological surgery
- Stage 2 or 3 lymphedema
- Decompensated heart, lung, or kidney failure
- Uncontrolled hypertension
- Presence of systemic infection
- Local infections in the lower extremity such as erysipelas or cellulitis
- Venous insufficiency (e.g., deep vein thrombosis)
- Any neuromuscular or orthopedic disease affecting lower extremity walking
- Presence of balance disorders
- Bilateral lymphedema
- Presence of lipolymphedema
- Fracture in the lower extremity
- Active metastasis
- Speech or language problems
- Pregnancy
- Inability to continue treatment (5 days a week for a total of 4 weeks)
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Turkey (Türkiye)
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.